McGinley Orthopedics, a developer of patented drill technology for surgeons, has named Carl O'Connell as its new CEO, effective 4 February 2019, it was reported yesterday.
Prior to joining McGinley Orthopedics, O'Connell most recently served as CEO of Xtant Medical. Prior to that he was vice president of Global Marketing--Extremities for Wright Medical Group Inc. During his tenure as global vice president of marketing for Stryker Spine, O'Connell drove marketing leadership and brand differentiation programs to support a double-digit growth imperative. O'Connell served as the president and CEO of MedSurg-ITOCHU International. He has more than 30 years of experience in the healthcare and medical device arena. In addition to his corporate positions, he also served as a principal at Hudson Healthcare Partners, and president of Carl Zeiss Surgical Inc. Throughout his career, O'Connell has launched and commercialised more than 100 products and participated in numerous M&A events.
McGinley Orthopedics co-founder, Dr Joseph McGinley, said, 'We are proud to announce Carl O'Connell as our new CEO. With his extensive leadership in the medical device industry and commercialisation expertise, we are confident he is the right choice to lead McGinley Orthopedics to new levels of growth and success. Carl has served as an advisor to the company for the last five years, and we share his enthusiasm for the outlook of the company.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer